• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Helix BioMedix Inc

  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Programs
    • Pharma
    • Personal Care
  • News
    • Press Releases
    • Presentations
    • Scientific Publications
  • Investors
    • Stock Information
    • IR Updates
    • Proxy
    • Corporate Governance
  • Contact Page
You are here: Home / About

About

Helix BioMedix a is leading peptide discovery and development biopharmaceutical company with an initial focus in dermatology and skin health.  Our intellectual property portfolio offers multiple pathways for commercialization in this area ranging from Rx dermatology to aesthetic dermatology and personal care.  In addition, our innovative peptide library is extensive and diverse, allowing us to approach additional markets such as agricultural and industrial use.

Our mission is to enrich clinical practice and the patient/consumer experience by developing new treatment options for dermatologic conditions which offer the therapeutic effectiveness and safety benefits of our advanced bioactive small molecule technology.  We are committed to transforming the treatment of skin conditions by addressing unmet needs in elegant, life-enhancing topical formulations.

Primary Sidebar

Footer

COMPANY PROFILE

Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum.  Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.

 

 

 

 

Terms & Conditions | Privacy Policy

Search

 

©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2025 · Executive Pro On Genesis Framework · WordPress · Log in